Yinghui Wang, Xin-xin Li, Tao Li
Jul 15, 2014
Citations
0
Influential Citations
0
Citations
Journal
International Medicine and Health Guidance News
Abstract
Objective To evaluate the pharmacoeconomical outcome of anti-ventricular arrhythmia drugs,to provide reference for national selection of anti-ventricular arrhythmia drugs.Methods By searching literatures,collected the information of efficacy and safety of 10 kinds of anti-ventricular arrhythmia drugs; took the top limit of monthly expense as cost and efficiency as effectiveness to do cost-effectiveness analysis and sensitivity analysis.Results The total effective rate of anti-ventricular arrhythmia medicine was 78.71%,and drug adverse reaction rate was 13.97%.The low cost-effectiveness drugs were mexiletine < atenolol < propafenone < amiodarone < sotolol < metoprolol < bisoprolol; the high cost-effectiveness drugs were moracizine > Wenxin grannle > SRYX capsule; the low ADR rate drugs were bisoprolol < SRYX capsule < Wenxin grannle < atenolol < metoprolol; the high ADR rate drugs were sotolol > moracizine > mexiletine > amiodarone > propafenone.Conclusion Atenolol,metoprolol,bisoprolol belong to high efficient,safe and low cost medicine.In the drug economics we encourage to use high efficient,safe and low cost drugs. Key words: Anti-ventricular arrhythmia drugs; Efficacy; Safety; Pharmacoeconomics; Cost-effectiveness analysis